Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Lowered to $125 at RBC Capital

April 18, 2024 6:19 AM
RBC Capital analyst Shagun Singh lowered the price target on Abbott Labs (NYSE: ABT) to $125.00 (from $128.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles